Your session is about to expire
← Back to Search
This trial is testing a new way to treat tumors near the spinal cord by combining two existing treatment methods. The goal is to improve tumor control and quality of life for patients with spinal metastasis.
- Spinal Metastases
- Spinal Cord Disease
- Spinal Cord Compression
- Spinal Cord Tumors
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2019 Phase 2 trial • 32 Patients • NCT01573702
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You can't handle being put to sleep or lying face down.You need to have a spinal procedure done with or without image guidance.You have certain types of tumors that are sensitive to radiation therapy, like lymphoma or small cell carcinoma.You cannot have a magnetic resonance imaging (MRI) scan of your spine.You cannot lie down flat on a table for more than 60 minutes.You are expected to live for at least 3 more months.The area of the spine that needs treatment is between the T2 and L1 vertebrae.You are able to perform daily activities without help, or your overall health is fairly good.You have received radiation treatment to the same area of the spine less than 3 months ago.You have severe spinal cord compression causing acute problems with moving your arms or legs.You have been diagnosed with a solid cancer tumor, such as lung, breast, prostate, kidney, skin, stomach, bone, thyroid, head and neck, or an unknown origin tumor.Your MRI shows a certain level of spinal cord compression.You can't have more than 3 areas in your spine with cancer that need to be treated with radiation at one time or over three sessions.Your affected arms or legs have strong muscle strength, rated 4 out of 5 or higher.You had radiation treatment at the same place more than 3 months ago.You must be 18 years old or older. This technique might not be safe for younger people whose bones are still growing.You have been diagnosed with a solid cancer that is not highly sensitive to radiation.
- Group 1: Experimental Treatment of Laser Interstitial Thermal Ablation Therapy and Stereotactic Radiosurgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for participants in this investigation?
"Affirmative. According to clinicaltrials.gov, this research is still actively gathering participants for the experiment. The project was first announced on September 2nd 2021 and most recently updated July 26th 2022 with the intention of recruiting 60 test subjects from a single site."
What is the estimated sample size for this medical trial's participants?
"Affirmative. The information hosted on clinicaltrials.gov implies that this experiment is actively recruiting participants, having been initially published on September 2nd 2021 and last amended on July 26th 2022. 60 patients are sought to take part at 1 site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends